20918 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
USE OF MEGANUCLEASES FOR INDUCING HOMOLOGOUS RECOMBINATION EX VIVO AND IN TOTO IN VERTEBRATE SOMATIC TISSUES AND APPLICATION THEREOF
#3602USE OF MEGANUCLEASES FOR INDUCING HOMOLOGOUS RECOMBINATION EX VIVO AND IN TOTO IN VERTEBRATE SOMATIC TISSUES AND APPLICATION THEREOF
#3603Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof
#3604Methods of identifying inhibitors of FGF23 binding to the binary FGFR-klotho complex for the treatment of hypophosphatemia
#3605Approach to treat intraocular hypertension
#3606Genes and proteins associated with angiogenesis and uses thereof
#3607Method of reducing cell death by administering a paracrine factor of a mesenchymal stem cell
#3608ANTIBIOFILM GLYCOPEPTIDES
#3609Expanding the eukaryotic genetic code
#3610Means and methods for the specific modulation of target genes in the CNS and the eye and methods for their identification
#3611NOVEL COMPOUNDS FOR MODULATING NEOVASCULARISATION AND METHODS OF TREATMENT USING THESE COMPOUNDS
#3612Prevention and Treatment of Amyloidogenic Disease
#3613B7-H4 fusion proteins and methods of use thereof
#3614USE OF REPEAT SEQUENCE PROTEIN POLYMERS IN PERSONAL CARE COMPOSITIONS
#3615Preparation of a Therapeutic Composition
#3616Compositions and methods for preventing or treating cancer
#3617METHODS OF TREATING A PATIENT RECEIVING A CARDIAC STENT IMPLANT
#3618Compositions and methods for the treatment of myocardial ischemia/reperfusion injury with Annexin A1 short peptide
#3619Means and Methods for Diagnosing and/or Treating a Subject at Risk of Developing Heart Failure
#3620Pre-Transplant Accommodated Organs Resistant To Anti-Donor Immunity
#3621Purified amniotic membrane compositions and methods of use
#3622HMGN polypeptides as immune enhancers and HMGN antagonists as immune suppressants
#3623Process for the production of immunogenic compositions
#3624Inhibitors of phosphatase and tensin homolog (PTEN) conjugates
#3625METHODS OF INDUCING TOLERANCE
#3626Methods for identifying candidate modulators of NOTUM activity
#3627Methods of controlling tumorigenesis and diagnosing the risk thereof
#3628Oxidant resistant apolipoprotein A-1 and mimetic peptides
#3629Methods for modulating inflammatory and/or immune responses
#3630Methods for modulating inflammatory and/or immune responses
#3631Method and system of runtime analysis
#3632Apolipoprotein A1 Mimetics and Uses Thereof
#3633Polypeptoid pulmonary surfactants
#3634COMPOSITIONS AND METHODS FOR THE SYSTEMIC TREATMENT OF ARTHRITIS
#3635Hemojuvelin fusion proteins
#3636Inhibitors of guanine exchange factors and their use as anticancer drugs
#3637Expanding the eukaryotic genetic code
#3638Compositions and Methods for Identifying Agents Which Modulate PTEN Function and PI-3 Kinase Pathways
#3639Treatment of skin conditions by Dickkopf1 (DKK1)
#3640Compositions and methods for regulating SAS1R
#3641AGENT FOR INTRA-ARTICULAR INJECTION
#3642Combination immunotherapy for the treatment of cancer
#3643Methods and compositions for modulating adipocyte function
#3644Charged lipoprotein complexes and their uses
#3645Biglycan and related therapeutics and methods of use
#3646TUSC2 THERAPIES
#3647Perivascular stem cell composition for bone
#3648Methods for promoting wound healing and/or reducing scar formation
#3649REGULATION OF EPITHELIAL TISSUE BY HEDGEHOG-LIKE POLYPEPTIDES, AND FORMULATIONS AND USES RELATED THERETO
#3650Methods for reducing GnRH-positive tumor cell proliferation using the GnRH antagonist IN3
#3651METHODS OF IMPROVING CARDIAC FUNCTION AND ATTENUATING AND/OR PREVENTING CARDIAC REMODELING WITH HSP20
#3652Cardiac Compositions
#3653METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING AUTOIMMUNE DISEASES USING IMMUNOMODULATORY AGENTS
#3654THERAPEUTIC AGENT FOR PULMONARY SMALL CELL CARCINOMA
#3655LIPOPROTEIN COMPLEXES AND MANUFACTURING AND USES THEREOF
#3656Stable formulations for parenteral injection of peptide drugs
#3657Method for inducing differentiation of dental pulp cells into odontoblasts
#3658Neural Regeneration
#3659Fusion proteins
#3660Protection Against and Treatment of Ionizing Radiation
#3661Use of an agent that restores tissue perfusion and oxygenation
#3662Islet1 (Isl1) and hearing loss
#3663NGAL FOR DIAGNOSIS OF RENAL CONDITIONS
#3664METHODS FOR PROTECTING DOPAMINERGIC NEURONS FROM STRESS AND PROMOTING PROLIFERATION AND DIFFERENTIATION OF OLIGODENDROCYTE PROGENITORS BY NRG-2
#3665Methods and compositions for treating neurodegenerative disorders and Alzheimer's disease and improving normal memory
#3666Anti-reflux infant nutrition
#3667COMPOSITIONS AND METHODS FOR MODULATING STEM CELLS AND USES THEREOF
#3668MODULATION OF GLUT4 GENE PROMOTER ACTIVITY BY AHNAK
#3669Method to Detect or Treat Painful Bladder Syndrome based on Relation to Quinone Oxidoreductase 1
#3670USE OF PROTEIN KINASE C DELTA (PKCD) INHIBITORS TO TREAT DIABETES, OBESITY, AND HEPATIC STEATOSIS
#3671TREATMENT OF HIV
#3672Use of gelsolin to diagnose and treat inflammatory diseases
#3673Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment
#3674Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition
#3675Immobilized biologically active entities having a high degree of biological activity
#3676Immunogenic epitopes as targets for universal cancer vaccines
#3677MEDICAL UTILITY OF GLYCAN-BINDING PROTEINS AND GLYCANS
#3678Autism-associated biomarkers and uses thereof
#3679LAMININS, DERIVATIVES, AND COMPOSITIONS INCLUDING SAME AND METHODS FOR THEIR THERAPEUTIC USE
#3680Stem Cell Conditioned Medium Compositions
#3681Inhibiting Aberrant Blood Vessel Formation Using Growth Factor Retargeted Endopeptidases
#3682SCGB3A2 as a growth factor and anti-apoptotic agent
#3683METHODS OF ALTERING BONE GROWTH BY ADMINISTRATION OF SOST OR WISE ANTAGONIST OR AGONIST
#3684CAPCNA PEPTIDE THERAPEUTICS FOR CANCER
#3685METHODS OF TREATING INFLAMMATION BY ADMINISTRATION OF HEME OXYGENASE-1 AND PRODUCTS OF HEME DEGRADATION
#3686Regulatory T cell mediator proteins and uses thereof
#3687Aptamers to tissue factor pathway inhibitor and their use as bleeding disorder thereapeutics
#3688Method and means for treatment of osteoarthritis
#3689Tetranectin-apolipoprotein A-I, lipid particles containing it and its use
#3690METHOD FOR PRODUCING A LIPID PARTICLE, THE LIPID PARTICLE ITSELF AND ITS USE
#3691TREATMENT OF COMPLEMENT-ASSOCIATED DISORDERS
#3692Treatment of pain
#3693Lipid formulation
#3694Inhibition of endosomal toll-like receptor activation
#3695MOLECULAR TARGETS FOR TREATMENT OF INFLAMMATION
#3696Bioerodible silicon-based devices for delivery of therapeutic agents
#3697Methods and compositions for the inhibition of transplant rejection
#3698COMPOSITION COMPRISING A HAEMATIC COMPONENT AND ITS USE FOR THE TREATMENT OF DEGENERATIVE JOINT DISEASE
#3699Manufacturing and Purification Processes of Complex Protein found in Fraction IV to make a separated Apo, Transferrin , and Alpha 1 Anti strepsin (A1AT) or A combined Transferrin / Apo/Human Albumin/A1AT and all new found proteins
#3700Klotho protein and related compounds for the treatment and diagnosis of cancer
#3701Use of HASF as a Protective Agent Against Ischemic Tissue Damage
#3702Methods and compositions for specific modulation of MCL-1
#3703DELIVERY SYSTEMS FOR BIOACTIVE AGENTS
#3704METHODS AND COMPOSITIONS FOR INHIBITING C-MET DIMERIZATION AND ACTIVATION
#3705Methods of stimulating liver regeneration
#3706Compositions and Methods for Modulating PGC-1Alpha to Treat Neurological Diseases and Disorders
#3707INHIBITION OF HAIR FOLLICLE GROWTH BY THE WNT INHIBITOR DKK1
#3708Methods To Identify Compounds Useful For The Treatment Of Proliferative And Differentiative Disorders
#3709Compositions Containing JARID1B Inhibitors and Methods for Treating Cancer
#3710CUSTOM-MADE MEGANUCLEASE AND USE THEREOF
#3711Methods for treating neurological conditions and compositions and materials therefor
#3712Means for treating synucleinopathies
#3713Influenza prevention and treatment composition
#3714Composition for inducing migration of neural stem cells containing periostin as effective ingredient
#3715Methods for improving kidney function
#3716Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
#3717DIAGNOSTIC MARKERS OF HUMAN FEMALE INFERTILITY
#3718Chimeric toll-like receptor/MD-2 polypeptides and methods of use thereof
#3719COMPOSITIONS AND METHODS TO GENERATE PILOSEBACEOUS UNITS
#3720Use of Inclusion Bodies as Therapeutic Agents
#3721Compositions and Methods for the Systemic Treatment of Arthritis
#3722Method for preventing and treating cardiovascular diseases with BRCA1
#3723RCA LOCUS ANALYSIS TO ASSESS SUSCEPTIBILITY TO AMD AND MPGNII
#3724HSP therapy in conjunction with a low antigenicity diet
#3725Liquid enteral nutritional composition with a low monovalent metal ion content
#3726Technology for the Preparation of Microparticles
#3727Method of treating hypertrophic cardiomyopathy
#3728Method for increasing muscle mass and strength
#3729Inhibition of prion propagation by receptor associated protein (RAP), its derivatives, mimetics and synthetic peptides
#3730Application and uses of PRG4 and therapeutic modulation thereof
#3731Stable analogs of peptide and polypeptide therapeutics
#3732Peptide ligands for G-protein coupled receptors
#3733Muscle function enhancing peptide
#3734COMPOSITIONS AND METHODS FOR PROMOTING VASCULAR BARRIER FUNCTION AND TREATING PULONARY FIBROSIS
#3735COMPOSITIONS AND METHODS FOR THE REMOVAL OF BIOFILMS
#3736Agents capable of downregulating an MSF-A-dependent HIF-1alpha and use thereof in cancer treatment
#3737ACCELERATED EXTENSION OF AXONS
#3738Methods for treatment of Alzheimer's disease
#3739Infant nutritional compositions for preventing obesity
#3740METHODS OF INHIBITING ADVERSE CARDIAC EVENTS AND TREATING ATHEROSCLEROSIS AND CORONARY ARTERY DISEASE USING GALECTIN-3 BINDING PROTEIN (GAL-3BP, BTBD17B, MAC-2 BINDING PROTEIN)
#3741Superoxide dismutase variants and methods of use thereof
#3742Regulation of sodium channels by PLUNC proteins
#3743Use of liposomal Wnt composition to enhance osseointegration
#3744Carrier comprising a vitamin E derivative
#3745Cosmetic and therapeutic use of proteins of DJ-1 type for treating skin dryness
#3746PROTEIN WITH PROMOTING EFFECTS FOR AXONAL GROWTH OF NEURONS OF CENTRAL NERVOUS SYSTEM
#3747Compositions comprising polynucleotides encoding RDCVF1 or RDCVF2
#3748Methods of increasing RDCVF 1 or RDCVF 2 polypeptides in retinal cells
#3749Treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain
#3750Compositions and Methods for Modulating Immunodeficiency Virus Transcription
#3751Method of Inhibiting Smooth Muscle Cell Proliferation by Using Reconstituted HDL
#3752Modified defensins and their use
#3753Human skin equivalents expressing exogenous polypeptides
#3754Use of Vgll3 activity modulator for the modulation of adipogenesis
#3755Compositions comprising semaphorins for the treatment of angiogenesis related diseases and methods of selection thereof
#3756COMPOSITIONS, FORMULATIONS AND METHODS OF TREATING PREECLAMPSIA-TYPE DISORDERS OF PREGNANCY
#3757METHOD FOR CHONDROGENIC DIFFERENTIATION OF PLURIPOTENT OR MULTIPOTENT STEM CELLS USING WNT6
#3758TRUNCATED ACTIVIN TYPE II RECEPTOR AND METHODS OF USE
#3759Methods for treatment of stroke or cerebrovascular accidents using an ETB receptor agonist
#3760Use of antisecretory factors (AF) for optimizing cellular uptake
#3761SPARC ANGIOGENIC DOMAIN AND METHODS OF USE
#3762CHAPERONIN 10 IMMUNOSUPPRESSION
#3763CYTOKINES AND NEUROANTIGENS FOR TREATMENT OF IMMUNE DISORDERS
#3764INFERTILITY ASSOCIATED DEFB-126 DELETION POLYMORPHISM
#3765JNK INHIBITORS FOR USE IN TREATING SPINAL MUSCULAR ATROPHY
#3766Inhibitor against forming biofilm comprising κ-casein macropeptide
#3767MITOCHONDRIAL LOCALIZATION OF MUC1
#3768APPOPTOSIN AND USES THEREOF FOR TREATING NEURODEGENERATIVE DISEASE AND CANCER
#3769METHOD OF TREATING WOUNDS
#3770Sulfation of Wnt pathway proteins
#3771Anti-trypanosomal peptides and uses thereof
#3772Isoform Nell-1 peptide
#3773Use of modulators of compounds of TGF-β superfamily to regulate hepcidin-mediated iron metabolism
#3774Use of Guanylyl Cyclase C Agonists to Suppress Appetite
#3775RTEF-1 variants and uses thereof
#3776DNA vaccines encoding heat shock proteins
#3777USE OF DECORINE FOR INCREASING MUSCLE MASS
#3778WATER-IN-OIL TYPE EMULSION FOR TREATING A DISEASE OF THE EYE
#3779Reelin rescues congnitive function
#3780Method of inhibiting angiogenesis
#3781Treatment of subarachnoid hemorrhage with ApoE analogs
#3782METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF CANCER
#3783INTERLEUKIN-13 RECEPTOR ALPHA 2 PEPTIDE-BASED BRAIN CANCER VACCINES
#3784Therapeutic modulation of vaginal epithelium boundary lubrication
#3785Methods for Modulating Ovulation
#3786TNF-α antagonists containing IGFBP5
#3787Antagonists of MUC1
#3788Stabilized mutant opsin proteins
#3789MODIFICATION OF FEEDING BEHAVIOUR
#3790Stable Solid Formulations of GC-C Receptor Agonist Polypeptides Suitable for Oral Administration
#3791MIF antagonists
#3792Method for treating pulmonary hypertension
#3793Method of inducing T cell apoptosis by administering Altered Peptide Ligand
#3794Antiviral agent
#3795Method for Modulating Epithelial Stem Cell Lineage
#3796Amyloid beta(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof
#3797Methods of preventing rejection of transplanted tissue by administering anti-CD40L antibody and dendritic cells loaded with Hsp60sp peptide
#3798Methods and compositions comprising tau oligomers
#3799TARGETED NANOPARTICLES FOR CANCER AND OTHER DISORDERS
#3800Cancer therapy based on tumor associated antigens derived from cyclin D1
#3801USE OF A PEPTIDE IN THE TREATMENT OR PREVENTION OF METASTASIS
#3802Cancer Diagnosis and Treatment Methods of Use
#3803USING HEAT SHOCK PROTEINS TO IMPROVE THE THERAPEUTIC BENEFIT OF A NON-VACCINE TREATMENT MODALITY
#3804Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
#3805PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF LEFT VENTRICULAR DIASTOLIC DYSFUNCTION
#3806Method of treatment of type-1 diabetes with humanin analogues
#3807Promotion of healthy catch-up growth
#3808Methods of using vimentin to inhibit angiogenesis and endothelial cell proliferation
#3809METHODS FOR MAGNETIC RESONANCE IMAGING
#3810Chimeric RGMa polypeptides
#3811COMPOSITIONS AND METHODS FOR INCREASING LEAN MUSCLE MASS AFTER EXERCISE
#3812Polypeptides for Specific Targeting to Otx2 Target Cells
#3813Therapeutic Compositions for Treatment of Corneal Disorders
#3814COMPOSITIONS AND METHODS OF TREATING TUMORS
#3815Annexin and its use to treat inflammatory disorders
#3816Antagonistic peptides for frizzled-1 and frizzled-2
#3817Methods of administering lipocalins to treat metabolic disorders and cardiovascular diseases
#3818Treatment of Fibrosis related disorders
#3819Use Of Serine Protease Inhibitors In The Treatment Of Neutropenia
#3820THERAPEUTIC AGENT COMPRISING VASOHIBIN
#3821VECTOR(S) CONTAINING AN INDUCIBLE GENE ENCODING A CDK4/CDK6 INHIBITOR USEFUL FOR TREATING NEURODEGENERATIVE DISORDERS OR DISEASES ASSOCIATED WITH AN UNSCHEDULED ACTIVATION OF THE CELL CYCLE
#3822Inhibitors of NF-κB activity
#3823Hsp9O-targeted anti-cancer chimeric peptide
#3824ANTAGONISTS OF ACTRIIB AND USES FOR INCREASING RED BLOOD CELL LEVELS
#3825Methods and apparatus for creating particle derivatives of HDL with reduced lipid content
#3826Alpha B-crystallin as a therapy for ischemia or inflammation
#3827Methods of inhibiting cell death or inflammation in a mammal by administering a BCL protein
#3828PROPHYLACTIC / THERAPEUTIC AGENT FOR CANCER
#3829Anxiolytic compositions containing α-casein-derived peptides
#3830NORRIN IN THE TREATMENT OF DISEASES ASSOCIATED WITH AN INCREASED TGF-BETA ACTIVITY
#3831TAU PROTEASE COMPOSITIONS AND METHODS
#3832Compositions and methods for suppressing fibrocytes
#3833Methods of treating cognitive impairment
#3834Prevention and Treatment of Amyloidogenic Disease
#3835ApoE analogs and methods for their use
#3836Approach to the treatment of compartment syndrome
#3837COMPOSITIONS AND METHODS FOR TREATING CANCER
#3838Pathways to generate hair cells
#3839Methods for the reactivation of latent HIV using cytosine methylation inhibitors and NF-KB activators
#3840THE USE OF A NON-GLYCANATED POLYPEPTIDE FOR TREATING A CANCER
#3841Skin wound healing compositions and methods of use thereof
#3842Pharmaceutical compositions for treating or preventing bone conditions
#3843Treatment of amyloidoses using myelin basic protein and fragments thereof
#3844Use of the engrailed homeodomain protein as anxiolytic
#3845Use of the cathelicidin LL-37 and derivatives thereof for wound healing
#3846Immobilized biologically active entities having a high degree of biological activity
#3847Method to produce an immunoglobulin preparation with improved yield
#3848COMPOSITION AND METHODS FOR MODULATING TOLL-LIKE RECEPTOR ACTIVITY
#3849Removal of serine proteases by treatment with finely divided silicon dioxide
#3850CONJUGATES FOR THE ADMINISTRATION OF BIOLOGICALLY ACTIVE COMPOUNDS
#3851Modified vaccinia virus strains for use in diagnostic and therapeutic methods
#3852COMPOSITIONS AND METHODS TO MODULATE HAIR GROWTH
#3853Method of producing a paralytic peptide
#3854Administration of angiocidin for the treatment of leukemia
#3855Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof
#3856THERAPEUTIC AND DIAGNOSTIC METHODS RELATING TO CANCER STEM CELLS
#3857Use of ferritin to treat iron disorders
#3858High affinity antibodies against HMGB1 and methods of use thereof
#3859Use of Hsp70 as a regulator of enzymatic activity
#3860Aptamers to tissue factor pathway inhibitor and their use as bleeding disorder therapeutics
#3861METHODS FOR TREATMENT OF MICROBIAL DISORDERS
#3862Treatment of atherosclerosis with cholesterol ester transport protein mimotopes
#3863COMPOUNDS AND METHODS TO MEASURE METABOLIC FUNCTION AND RESTORE NORMAL METABOLIC FUNCTION
#3864ALPHA-FETOPROTEIN PEPTIDES AND USES THEREOF
#3865Compositions and methods for treating pigmentary conditions and melanoma
#3866METHODS OF INHIBITING VIRAL REPLICATION
#3867CD34 Stem Cell-Related Methods and Compositions
#3868Skin Treatment
#3869Apo A-I mimetic peptides and methods of treatment
#3870STING (STIMULATOR OF INTERFERON GENES), A REGULATOR OF INNATE IMMUNE RESPONSES
#3871Alzheimer's Disease Treatment Method
#3872TREATMENT OF PROLIFERATIVE DISORDERS WITH A DEATH RECEPTOR AGONIST
#3873ORALLY ADMINISTRABLE DOSAGE FORMS COMPRISING ANGIOGENIN AND USES THEREOF
#3874COMBINATION TREATMENTS COMPRISING PROTEASE BINDING PROTEINS FOR INFLAMMATORY DISORDERS
#3875Compositions and methods of treating cancer
#3876Catecholamine regulated protein
#3877Anti periodontitis-causing microorganism agent and medical or dental materials using the same
#3878METHODS AND RELATED KITS FOR TREATING AND REGENERATING TOOTH PULP AND PERIAPICAL TISSUES IN A MAMMAL
#3879Compositions and methods relating to prevention of chemotherapy-induced alopecia
#3880Method for treating diabetes using neurturin
#3881Oxidized Cardiolipin as a Novel Pro-Inflammatory Factor
#3882Composition comprising expression or activity inhibitors of ninjurin1 for the prevention and treatment of inflammatory disease
#3883Methods for promoting wound healing and muscle regeneration with the cell signaling protein Nell1
#3884Methods and reagents for the diagnosis, prevention and treatment of insulin resistance using beta-arrestin2 and its up-regulators
#3885METHOD OF INDUCING PROLIFERATION AND/OR DIFFERENTIATION OF NEURAL PRECURSOR CELLS BY INTRODUCING PROLACTIN OR WNT3A TO ACTIVATE LATENT NEURAL PRECURSOR CELLS
#3886IMMUNOMODULATING TUMOR NECROSIS FACTOR RECEPTOR 25 (TNFR25) AGONISTS, ANTAGONISTS AND IMMUNOTOXINS
#3887PREVENTION AND TREATMENT OF CUTANEOUS LUPUS ERYTHEMATOSUS
#3888RECOMBINANT HUMAN CC10 AND COMPOSITIONS THEREOF FOR USE IN THE TREATMENT OF NASAL RHINITIS
#3889PHARMACEUTICAL COMPOSITION FOR TREATING BONE DISEASES WHICH COMPRISES PROTEIN COMPRISING Frizzled1, Frizzled2 OR Frizzled7 EXTRACELLULAR CYSTEINE-RICH DOMAIN
#3890TREATMENT OF DISEASES AND CONDITIONS MEDIATED BY INCREASED PHOSPHORYLATION
#3891Treatment and/or Prevention of Non-Viral Epithelial Damage
#3892Compositions for protection and cellular delivery of interfering RNA
#3893PURGING OF AN EX VIVO HEMATOPOIETIC STEM CELL CULTURE OF CANCER CELLS
#3894Treatment of diseases and conditions mediated by increased phosphorylation
#3895NUTRITIONAL COMPOSITION FOR WOUND HEALING
#3896Apolipoprotein C-II or its active fractions for the prevention or treatment of obesity and related metabolic disorders
#3897Methods for the diagnosis and treatment of cancer based on AVL9
#3898Immunotherapy against several tumors including gastrointestinal and gastric cancer
#3899Modulating the alternative complement pathway
#3900USE OF P2X7 PATHWAY FOR ASSESSING THE SENSITIVITY OF A SUBJECT TO A CANCER TREATMENT